Intravesical chemotherapy of superficial bladder cancer.
D000042:Absorption; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism; D001500:BCG Vaccine / Q000008:administration & dosage; D002278:Carcinoma in Situ / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004724:Endoscopy; D005009:Ethoglucid / Q000008:administration & dosage; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D008970:Molecular Weight; D009364:Neoplasm Recurrence, Local; D013713:Teniposide / Q000008:administration & dosage; D013852:Thiotepa / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D008937:Mitomycins; D005009:Ethoglucid; D016685:Mitomycin; D004317:Doxorubicin; D013852:Thiotepa; D013713:Teniposide